electroCore to Announce Third Quarter Ended September 30, 2020 Financial Results on Thursday, November 12

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) will release its third-quarter financial results on November 12, 2020, after market close. A conference call is scheduled for the same day at 4:30 PM Eastern Time, where management will discuss these results and answer questions. The company focuses on non-invasive vagus nerve stimulation therapy for neurological conditions, primarily targeting cluster headaches and migraines. For additional details, visit their website or join the conference via the provided webcast link.

Positive

• Focus on non-invasive vagus nerve stimulation therapy for multiple neurological conditions.
• Potential for growth in the migraine and cluster headache treatment markets.

Negative

• None.

Conference Call to be Held at 4:30pm Eastern Time

BASKING RIDGE, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the third quarter ended September 30, 2020 after the close of the market on Thursday, November 12, 2020. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions.

Thursday, November 12 @ 4:30pm Eastern Time

Domestic:	877-407-4018
International:	201-689-8471
Conference ID:	13711577
Webcast:	http://public.viavid.com/index.php?id=141806

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097
jackie.dorsky@electrocore.com

FAQ

When will electroCore report its financial results for Q3 2020?

electroCore will report its financial results for Q3 2020 on November 12, 2020.

What time is the conference call for electroCore's financial results?

The conference call for electroCore's financial results will be held at 4:30 PM Eastern Time on November 12, 2020.

What is the primary focus of electroCore's business?

electroCore focuses on bioelectronic medicine, specifically non-invasive vagus nerve stimulation therapy for neurological conditions.

What conditions does electroCore's therapy target?

electroCore's therapy targets the preventative treatment of cluster headaches and migraines, as well as acute treatment for these conditions.